International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 July 2016

Summary

 

IBT Portfolio NAV (m)

223

Number of Portfolio Companies

84

Quoted Investments

58

Unquoted Investments

26

 

NAV % Quoted / Unquoted Split
NAV % by Geography

Quoted

89%

United States / Canada

75%

Unquoted

11%

Europe

25%

Total

100% 

Total

100%

 

 

 

 

 

NAV % by Therapeutic Areas
NAV % by Market Cap

 

 

Oncology

37%

Large Cap >USD10BN

68%

Orphan

22%

Mid Cap =USD1-10BN

6%

CNS

11%

Small Cap < USD1BN

26%

Ophtalmology

8%

 

 

Inflammation

5%

 

 

Medtech

2%

 

 

Other

15%

 

 

Total100%